-
2024-510972-19-00
4
2025-03-13
Primary mediastinal large B-cell lymphoma (PMBCL)
-
2024-517340-61-00
5
2024-11-19
Patients after curative intent resection of cholangiocarcinoma
(intrah
-
2023-508170-28-00
4
2024-08-07
alcohol-related liver disease
-
2023-506185-31-00
10
2024-07-18
Idiopathic pulmonary fibrosis (IPF)
-
2022-502653-34-01
11
2024-05-30
Atopic dermatitis and moderate-to severe atopic hand eczema
-
2023-503693-20-01
5
2024-04-10
Severe eosinophilic asthma
-
2022-501969-42-00
5
2024-03-28
Intermediate-stage hepatocellular carcinoma with beyond up-to-7 criter
-
2022-502378-17-00
4
2024-03-20
Pulmonary Arterial Hypertension
-
2023-504678-39-00
4
2024-03-13
Heart Failure
-
2023-505499-32-00
5
2024-03-08
Uncontrolled hypertension (uTHN) defined as blood pressure that remain
-
2023-503614-80-00
5
2023-12-14
Pulmonary Arterial Hypertension
-
2022-500897-32-00
5
2023-11-02
Chronic pain due to diabetic polyneuropathy
-
2022-500898-13-00
5
2023-11-02
Chronic Pain due to traumatic or post-operative peripheral Neuropathy
-
2022-500899-66-00
5
2023-11-02
Chronic pain due to central Neuropathy of any Genesis
-
2022-502151-54-00
5
2023-11-02
Chronic back pain
-
2022-501918-55-00
4
2023-09-12
Mild Alzheimer's disease
-
2022-502697-16-00
5
2023-08-29
Neurotrophic Keratopathy
-
2022-502643-35-00
5
2023-08-09
Fuchs Endothelial Corneal Dystrophy
-
2024-511752-40-00
5
2023-05-05
Fuchs Endothelial Corneal Dystrophy
-
2024-516300-41-00
5
2023-03-07
Multiple Myeloma
-
2024-513230-38-00
5
2022-12-15
Platinum-Resistant Epithelial Ovarian, Fallopian Tube, or Primary Peri
-
2024-516758-23-00
4
2022-09-19
Myopia progression in children
-
2023-507388-21-00
5
2022-09-08
Acute non-arteritic central retinal artery occlusion (CRAO)
-
2023-509139-16-00
5
2022-05-13
Therapeutic confirmatory (phase III)